Related Experiment Video
Updated: Jun 26, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Genotype-based matching to correct for population stratification in large-scale case-control genetic association
Weihua Guan1, Liming Liang, Michael Boehnke
1Department of Biostatistics and Center for Statistical Genetics, School of Public Health, University of Michigan, Ann Arbor, Michigan 48109-2029, USA.
Genetic Epidemiology
|January 27, 2009
Summary
Genetic similarity score matching (GSM) effectively controls false positives and enhances power in genome-wide association studies. This method ensures matched cases and controls share similar genetic backgrounds, improving disease-gene discovery.
Area of Science:
- Genetics
- Genomics
- Biostatistics
Background:
- Genome-wide association studies (GWAS) are crucial for understanding complex disease etiology.
- Population stratification in case-control studies can yield false associations or obscure true ones.
- Existing methods for controlling stratification have limitations.
Purpose of the Study:
- To introduce and evaluate a novel Genetic Similarity Score Matching (GSM) method.
- To improve the accuracy and power of association tests in GWAS.
- To provide an efficient approach for matched case-control analysis.
Main Methods:
- Developed GSM, a three-step method: calculating genetic similarity scores, matching cases and controls based on these scores, and employing conditional logistic regression.
- Utilized computer simulations to assess GSM's performance.
- Compared GSM against the genomic control method.
Main Results:
- GSM effectively controls false-positive rates in association studies.
- GSM demonstrates improved power to detect true disease-predisposing variants compared to genomic control.
- Simulations confirm GSM's robustness in managing population stratification.
Conclusions:
- GSM is a powerful and efficient method for matched analysis in GWAS and large-scale candidate gene studies.
- The proposed matching strategy, including pre-genotyping and post-genotyping refinement, is recommended for GWAS.
- GSM enhances the reliability of genetic association findings for complex diseases.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:25What is Population Genetics?
A population is composed of members of the same species that simultaneously live and interact in the same area. When individuals in a population breed, they pass down their genes to their offspring. Many of these genes are polymorphic, meaning that they occur in multiple variants. Such variations of a gene are referred to as alleles. The collective set of all the alleles within a population is known as the gene pool.While some alleles of a given gene might be observed commonly, other variants...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:25Strategies for Assessing and Addressing Confounding
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...